Skip to main content

Find Clinical Trials

Home
Conditions
Tumor Virus Infections

Clinical trial condition

Tumor Virus Infections

Explore clinical trials studying Tumor Virus Infections. Study availability and eligibility vary by location and protocol.

1,486 public trials 253 recruiting studies

Refine in advanced search Browse all conditions

Tumor Virus Infections trial results

Recruiting

A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC.

NCT06797986

Conditions: Carcinoma, Carcinoma, Squamous Cell, Communicable Diseases, +21 more
Locations: Seoul National Univesity Hospital Seoul, South Korea

Sevrance Hospital Seoul, South Korea

View Trial Details

Recruiting

A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL)

NCT06789159

Conditions: DNA Virus Infections, Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed, +6 more
Locations: University of Kentucky Lexington, Kentucky, United States

View Trial Details

Recruiting

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

NCT03810196

Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +30 more
Locations: Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)

NCT07281430

Conditions: Cervical Carcinoma, Communicable Diseases, DNA Virus Infections, +23 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

Louisiana State University Lafayette, Louisiana, United States

Louisiana State University Health Science Center New Orleans, Louisiana, United States

View all 18 locations

View Trial Details

Recruiting

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

NCT07115043

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations: Research Site Grand Rapids, Michigan, United States

Research Site St Louis, Missouri, United States

Research Site Pittsburgh, Pennsylvania, United States

Research Site Houston, Texas, United States

View all 13 locations

View Trial Details

Recruiting

Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation.

NCT07685457

Conditions: BKV Infection, CMV Infection, Cytomegalovirus Infections, +7 more
Locations: The Catholic University of Korea Seoul St.Mary's Hospital Seoul, South Korea

View Trial Details

Recruiting

Allo HSCT Using RIC and PTCy for Hematological Diseases

NCT05805605

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Biphenotypic Acute Leukemia, +54 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Recruiting

Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia

NCT06738368

Conditions: B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Burkitt Lymphoma, DNA Virus Infections, +21 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

NCT00967785

Conditions: Agammaglobulinemia, Agranulocytosis, Blood Protein Disorders, +21 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

NCT03150693

Conditions: B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States

View all 460 locations

View Trial Details